10-propargyl-10-deazaaminopterin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cairo, MS; Dhir, A; Hill, B; Waite, ES; Xavier, AC | 1 |
| Gumbs, AA; MacGregor-Cortelli, B; Neylon, E; O'Connor, OA; Patterson, M; Zain, J | 1 |
2 other study(ies) available for 10-propargyl-10-deazaaminopterin and Liver Neoplasms
| Article | Year |
|---|---|
Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma.
Topics: Adolescent; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Lymphoma, T-Cell; Prednisone; Prognosis; Splenic Neoplasms | 2020 |
Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia.
Topics: Aminopterin; Fatal Outcome; Hematologic Agents; Humans; Laparoscopy; Liver Neoplasms; Lymphoma, T-Cell; Male; Middle Aged; Splenectomy; Splenic Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult | 2009 |